Patents by Inventor Soyan Lieberman

Soyan Lieberman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DGAT genes and methods of use for triglyceride production in recombinant microorganisms
    Patent number: 9328336
    Abstract: The present invention provides diacylglycerol acyltransferase (DGAT) genes, including genes encoding localization peptides. The present invention also provides recombinant cells, such as algae, transformed with DGAT genes and methods of using such recombinant cells to produce triglyceride.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: May 3, 2016
    Assignee: EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
    Inventors: Jane C Schneider, Eric Moellering, Erik Holtzapple, Soyan Lieberman, Gena Roy
  • Acetyl CoA carboxylases
    Patent number: 9133489
    Abstract: Provided herein are novel ACCases and nucleotides encoding the same, that when introduced into a cell or organism results in an increase and/or accumulation of fatty acids, glycerol lipids, and/or oils in the cell or organism, and/or a change in the types of fatty acids, glycerol lipids, and/or oils that are normally present in the cell or organism. Also provided herein are organisms transformed with the novel ACCases.
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: September 15, 2015
    Assignee: SAPPHIRE ENERGY, INC.
    Inventors: Craig A. Behnke, David Molina, Soyan Lieberman, Jamie Bacher, Shuiqin Wu
  • Tetraselmis promoters and terminators for use in eukaryotic cells
    Patent number: 8883993
    Abstract: The present invention provides novel promoter and terminator sequences for use in gene expression in eukaryotic cells, such as algal cells. The invention further provides expression cassettes comprising a promoter, as described herein, operably linked to a gene. The invention further provides expression vectors and host eukaryotic cells, such as algal cells, for expressing a protein encoded by the gene; and methods for stably transforming eukaryotic algae such as Tetraselmis with transgenes.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: November 11, 2014
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Jane C. Schneider, Soyan Lieberman, Bo Liu, Eric R. Moellering, John H. Verruto, Amanda Skaggs
  • TETRASELMIS PROMOTERS AND TERMINATORS FOR USE IN EUKARYOTIC CELLS
    Publication number: 20140154806
    Abstract: The present invention provides novel promoter and terminator sequences for use in gene expression in eukaryotic cells, such as algal cells. The invention further provides expression cassettes comprising a promoter, as described herein, operably linked to a gene. The invention further provides expression vectors and host eukaryotic cells, such as algal cells, for expressing a protein encoded by the gene; and methods for stably transforming eukaryotic algae such as Tetraselmis with transgenes.
    Type: Application
    Filed: December 4, 2012
    Publication date: June 5, 2014
    Applicant: ExxonMobil Research and Engineering Company
    Inventors: Jane C. Schneider, Soyan Lieberman, Bo Liu, Eric R. Moellering, John H. Verruto, Amanda Skaggs
  • DGAT GENES AND METHODS OF USE FOR TRIGLYCERIDE PRODUCTION IN RECOMBINANT MICROORGANISMS
    Publication number: 20140106417
    Abstract: The present invention provides novel diacylglycerol acyltransferase (DGAT) genes, including novel genes encoding localization peptides. The present invention also provides recombinant cells, such as algae, transformed with DGAT genes and methods of using such recombinant cells to produce triglyceride.
    Type: Application
    Filed: October 16, 2012
    Publication date: April 17, 2014
    Inventors: Jane C Schneider, Eric Moellering, Erik Holtzapple, Soyan Lieberman, Gena Roy
  • Composition and method for treatment of tumors
    Patent number: 8329669
    Abstract: The present invention relates to a composition which is useful in the treatment of a tumor, a method for making such a composition, and a method for using such a composition. The invention relates also to a method for assaying for inhibitors of the activity of Core 1 protein and/or other proteins of the respiratory complex III of mitochondria.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: December 11, 2012
    Assignee: Sanofi
    Inventors: Paul August, Waan Jeng Huang, Sridaran Natesan, Soyan Lieberman
  • NOVEL ACETYL CoA CARBOXYLASES
    Publication number: 20120231546
    Abstract: Provided herein are novel ACCases and nucleotides encoding the same, that when introduced into a cell or organism results in an increase and/or accumulation of fatty acids, glycerol lipids, and/or oils in the cell or organism, and/or a change in the types of fatty acids, glycerol lipids, and/or oils that are normally present in the cell or organism. Also provided herein are organisms transformed with the novel ACCases.
    Type: Application
    Filed: September 13, 2010
    Publication date: September 13, 2012
    Applicant: Sapphire Energy, Inc.
    Inventors: Craig A. Behnke, David Molina, Soyan Lieberman, Jamie Bacher, Shuiqin Wu
  • COMPOSITION AND METHOD FOR TREATMENT OF TUMORS
    Publication number: 20100035807
    Abstract: The present invention relates to a composition which is useful in the treatment of a tumor, a method for making such a composition, and a method for using such a composition. The invention relates also to a method for assaying for inhibitors of the activity of Core 1 protein and/or other proteins of the respiratory complex III of mitochondria.
    Type: Application
    Filed: July 25, 2007
    Publication date: February 11, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Paul August, Waan Jeng Huang, Sridaran Natesan, Soyan Lieberman